Mavyret is intended to treat adults with all types of chronic hepatitis C virus with mild or no cirrhosis who have not previously received treatment for the illness. Patients with moderate to severe ...

Large study in veterans detects increased pancreatic cancer risk, needs validation ...

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic ...

Findings showed that in patients treated with glecaprevir/pibrentasvir, the overall SVR12 rate was 96%, with 0 patients experiencing virologic failure. The Food and ...